Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 53661-18-0 | MDL No. : | MFCD01861267 |
Formula : | C8H13ClN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YGFUKCJADFMHGW-UHFFFAOYSA-N |
M.W : | 172.66 | Pubchem ID : | 2760970 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 50.39 |
TPSA : | 38.05 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.45 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.68 |
Log Po/w (WLOGP) : | 2.15 |
Log Po/w (MLOGP) : | 2.34 |
Log Po/w (SILICOS-IT) : | 1.11 |
Consensus Log Po/w : | 1.66 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.87 |
Solubility : | 0.233 mg/ml ; 0.00135 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.13 |
Solubility : | 0.128 mg/ml ; 0.000739 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.85 |
Solubility : | 0.243 mg/ml ; 0.00141 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.22 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | Stage #1: With hydrogenchloride; sodium nitrite In water at 0℃; for 1 h; Stage #2: With hydrogenchloride; tin(ll) chloride In water at -10℃; for 1.5 h; |
150 ml of water and 160 ml of 12N hydrochloric acid are added to 24.2 g (0.2 mol) of 4-ethylaniline. The mixture is cooled to 0 C. and 14 g (0.2 mol) of sodium nitrite dissolved in 140 ml of water are then introduced dropwise. After 1 hour at 0 C., 112 g (0.496 mol) of stannous chloride dihydrate dissolved in 90 ml of 12 N hydrochloric acid are added to the reaction mixture, at 10 C. After 1 hour 30 at 10 C., the reaction mixture is ltered in order to obtain a brown solid, m.p.=198 C.; yield=95percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | Stage #1: With potassium phosphate; N,N'-bis(2,5-dimethylpyrrol-1-yl)oxalamide; cetyltrimethylammonim bromide; copper(I) bromide In water at 80℃; for 0.166667 h; Sealed tube; Inert atmosphere Stage #2: With hydrazine hydrate In water at 80℃; for 2 h; Sealed tube; Inert atmosphere Stage #3: With hydrogenchloride In dichloromethane; water |
General procedure: CuBr (36 mg, 0.25 mmol, 2.5 mol percent), L3 (110 mg, 0.4 mmol,4 mol percent), H2O (0.5 mL), and K3PO4 (254 mg, 1.2 mmol) were mixedin a 15 mL screw cap test tube. After STAC (110 mg, 0.3 mmol,3 mol percent) and aryl bromide (10 mmol) were added, the resulting mixture was stirred at 80-110° C (bath temperature) for 10 min.Then K3PO4 (2.29 g, 10.8 mmol) and N2H4*H2O (1 g, 20 mmol) were added and argon (flow rate 5-7 mL/min) was bubbled through thereaction mixture for 5 min.28 The reaction mixture was stirred ina closed test tube at 80-110° C (bath temperature) for 1-2 h until complete consumption of starting material was observed as monitoredby TLC (eluentehexane), then cooled to room temperatureand diluted with SH2Cl2 (50 mL). The resulting solutionwas filteredand washed with brine (225 mL). Aq HCl (37percent) was added to the CH2Cl2 solution dropwise until pH 3-4. The formed precipitate was filtered, washed with SH2Cl2 (15 mL) and dried atroom temperature. NMR spectra of certain synthesized aryl hydrazine hydrochlorides showed that they contained 1-5 mol percent of the corresponding aniline hydrochlorides as impurities (see Supplementary data). Analytical samples of aryl hydrazine hydrochlorides were purified via precipitation from methanol solution by adding 2-3 volumes of diethyl ether. |
[ 60481-51-8 ]
(3,4-Dimethylphenyl)hydrazine hydrochloride
Similarity: 0.97
[ 109221-88-7 ]
[1,1'-Biphenyl]-3-ylhydrazine hydrochloride
Similarity: 0.94
[ 637-60-5 ]
p-Tolylhydrazine hydrochloride
Similarity: 0.94
[ 2243-58-5 ]
Naphthalen-2-ylhydrazine hydrochloride
Similarity: 0.92
[ 60481-36-9 ]
3,5-Dimethylphenylhydrazine hydrochloride
Similarity: 0.91
[ 60481-51-8 ]
(3,4-Dimethylphenyl)hydrazine hydrochloride
Similarity: 0.97
[ 109221-88-7 ]
[1,1'-Biphenyl]-3-ylhydrazine hydrochloride
Similarity: 0.94
[ 637-60-5 ]
p-Tolylhydrazine hydrochloride
Similarity: 0.94
[ 2243-58-5 ]
Naphthalen-2-ylhydrazine hydrochloride
Similarity: 0.92
[ 60481-36-9 ]
3,5-Dimethylphenylhydrazine hydrochloride
Similarity: 0.91
[ 60481-51-8 ]
(3,4-Dimethylphenyl)hydrazine hydrochloride
Similarity: 0.97
[ 109221-88-7 ]
[1,1'-Biphenyl]-3-ylhydrazine hydrochloride
Similarity: 0.94
[ 637-60-5 ]
p-Tolylhydrazine hydrochloride
Similarity: 0.94
[ 2243-58-5 ]
Naphthalen-2-ylhydrazine hydrochloride
Similarity: 0.92
[ 60481-36-9 ]
3,5-Dimethylphenylhydrazine hydrochloride
Similarity: 0.91